Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteers Essential Hypertension”

Showing 18 of 0 results

Not applicableStudy completedNCT01743352
What this trial is testing

Comparison of Ultrafast Echo With Echotracking

Who this might be right for
Essential Untreated HypertensionHealthy Volunteers
French Cardiology Society 57
Early research (Phase 1)Study completedNCT02579356
What this trial is testing

To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers

Who this might be right for
Diseases of the Circulatory SystemEssential Hypertension
Samil Pharmaceutical Co., Ltd. 48
Early research (Phase 1)Study completedNCT00938262
What this trial is testing

Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 24
Early research (Phase 1)Study completedNCT00991705
What this trial is testing

Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 28
Early research (Phase 1)Study completedNCT00937534
What this trial is testing

Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 22
Early research (Phase 1)Study completedNCT05993806
What this trial is testing

A Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy Volunteers

Who this might be right for
Essential Hypertension
Celltrion 50
Early research (Phase 1)Looking for participantsNCT07803835
What this trial is testing

Phase 1 Clinical Study of MWX401 Injection in Chinese Healthy Participants and Participants With Mild Hypertension

Who this might be right for
Essential HypertensionHealthy Volunteers
Shanghai Minwei Biotechnology Co., Ltd 46
Early research (Phase 1)Study completedNCT06884085
What this trial is testing

Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227B

Who this might be right for
Primary Hypertension
Addpharma Inc. 70
Early research (Phase 1)Not Yet RecruitingNCT07421401
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fasting Conditions

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 58
Early research (Phase 1)Not Yet RecruitingNCT07421414
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fed Conditions

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 48
Early research (Phase 1)Study completedNCT01842230
What this trial is testing

Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine

Who this might be right for
Essential HypertensionHyperlipidemia
Chong Kun Dang Pharmaceutical 24
Early research (Phase 1)Study completedNCT00923533
What this trial is testing

Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 34
Early research (Phase 1)Study completedNCT01227603
What this trial is testing

Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting Conditions

Who this might be right for
Hypertension, Essential
Bayer 49
Early research (Phase 1)Study completedNCT06744062
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 in Healthy Volunteers Fed Conditions

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 48
Early research (Phase 1)Study completedNCT01146938
What this trial is testing

A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers

Who this might be right for
Essential HypertensionHepatic Impairment
Boryung Pharmaceutical Co., Ltd 18
Early research (Phase 1)Study completedNCT01340131
What this trial is testing

CKD-828 (40/5mg) Pharmacokinetic Study

Who this might be right for
Hypertension
Chong Kun Dang Pharmaceutical 68
Early research (Phase 1)Not Yet RecruitingNCT07421388
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fed Conditions

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 48
Early research (Phase 1)Not Yet RecruitingNCT07421375
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fasting Conditions

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 58

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation